Laurion Capital Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,810
| Closed | -$102K | – | 336 |
|
|
2023
Q2 | $102K | Buy |
+3,810
| New | +$102K | ﹤0.01% | 285 |
|
|
2021
Q3 | – | Sell |
-4,052
| Closed | -$627K | – | 525 |
|
|
2021
Q2 | $627K | Sell |
4,052
-61,312
| -94% | -$9.49M | ﹤0.01% | 279 |
|
|
2021
Q1 | $10.3M | Hold |
65,364
| – | – | 0.06% | 117 |
|
|
2020
Q4 | $15.2M | Buy |
65,364
+55,381
| +555% | +$12.9M | 0.12% | 38 |
|
|
2020
Q3 | $2.19M | Buy |
+9,983
| New | +$2.19M | 0.03% | 148 |
|
|
2020
Q2 | – | Sell |
-667
| Closed | -$192K | – | 735 |
|
|
2020
Q1 | $192K | Buy |
+667
| New | +$192K | ﹤0.01% | 407 |
|
|
2014
Q3 | – | Sell |
-1,213
| Closed | -$847K | – | 235 |
|
|
2014
Q2 | $847K | Buy |
+1,213
| New | +$847K | 0.02% | 70 |
|